002644 佛慈製藥
按盤價 
8.880 -0.080 (-0.893%)
8.880 -0.080 (-0.893%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.109 | 3.398 | 3.879 | 6.519 | 5.835 |
| 總資產報酬率 ROA (%) | 1.525 | 2.404 | 2.617 | 4.383 | 3.936 |
| 投入資產回報率 ROIC (%) | 2.025 | 3.221 | 3.578 | 5.991 | 5.381 | 邊際利潤分析 |
| 銷售毛利率 (%) | 32.919 | 30.576 | 31.062 | 29.280 | 27.292 |
| 營業利潤率 (%) | 6.984 | 7.187 | 7.160 | 13.732 | 13.742 |
| 息稅前利潤/營業總收入 (%) | 6.357 | 6.528 | 6.591 | 11.809 | 12.474 |
| 淨利潤/營業總收入 (%) | 5.952 | 6.291 | 5.857 | 10.490 | 11.438 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 141.317 | 110.620 | 102.844 | 70.529 | 58.429 |
| 價值變動淨收益/利潤總額(%) | -13.281 | -10.462 | -5.501 | -0.992 | -0.766 |
| 營業外收支淨額/利潤總額(%) | -3.092 | -1.889 | -2.000 | -9.509 | -1.397 | 償債能力分析 |
| 流動比率 (X) | 3.104 | 3.218 | 2.649 | 2.403 | 2.760 |
| 速動比率 (X) | 2.316 | 2.322 | 1.858 | 1.734 | 2.070 |
| 資產負債率 (%) | 26.863 | 26.513 | 30.049 | 33.195 | 30.806 |
| 帶息債務/全部投入資本 (%) | -8.441 | -11.232 | -8.628 | -8.598 | -12.442 |
| 股東權益/帶息債務 (%) | -1,131.803 | -859.139 | -1,078.540 | -1,063.428 | -742.830 |
| 股東權益/負債合計 (%) | 268.707 | 273.346 | 229.753 | 198.687 | 222.825 |
| 利息保障倍數 (X) | -15.215 | -12.421 | -15.412 | -16.152 | -11.559 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 139.223 | 109.100 | 103.742 | 110.313 | 95.917 |
| 存貨周轉天數 (天) | 217.948 | 187.723 | 164.541 | 151.898 | 156.584 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/03/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
